NASDAQ:CASI
CASI Pharmaceuticals, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.casipharmaceuticals.comipo date
Jun 12, 1996
CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patients with multiple myeloma. The com...Show More
Earnings
Earnings Release in 13 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus